FDA approves new therapy for hard-to-treat metastatic melanoma ...Middle East

News channel - News
FDA approves new therapy for hard-to-treat metastatic melanoma
By Jen Christensen, CNN (CNN) — On Friday, the US Food and Drug Administration approved a new, first-of-its-kind therapy that could help patients with metastatic melanoma, a rare but deadly form of skin cancer. The drug, made by the California-based Iovance Biotherapeutics, is approved to treat patients for whom other medicines have failed and the skin cancer is unable to be removed with surgery, or the cancer has spread to other parts of the body. Amtagvi, as the treatment is called, is the first cellular therapy used to treat this form of solid tumor cancer. The company said the drug will be made in Philadelphia with the capacity to help up to “several thousand patients annually.”

Hence then, the article about fda approves new therapy for hard to treat metastatic melanoma was published today ( ) and is available on News channel ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA approves new therapy for hard-to-treat metastatic melanoma )

Apple Storegoogle play

Last updated :

Also on site :